S&P 500   3,831.70 (+0.06%)
DOW   31,063.14 (-1.08%)
QQQ   314.93 (+0.67%)
AAPL   122.80 (+1.50%)
MSFT   233.03 (+1.76%)
FB   262.09 (+2.91%)
GOOGL   2,026.49 (+0.52%)
AMZN   3,071.54 (+0.47%)
TSLA   672.48 (-1.43%)
NVDA   545.85 (+2.55%)
BABA   239.76 (-0.17%)
CGC   32.42 (-2.38%)
GE   12.63 (-1.02%)
MU   91.20 (+3.50%)
NIO   46.10 (-1.52%)
AMD   84.02 (+1.94%)
T   28.00 (-2.20%)
F   11.72 (-0.34%)
ACB   10.65 (-1.57%)
DIS   189.03 (-1.02%)
BA   211.68 (-2.20%)
NFLX   540.54 (-1.13%)
BAC   34.94 (-2.76%)
S&P 500   3,831.70 (+0.06%)
DOW   31,063.14 (-1.08%)
QQQ   314.93 (+0.67%)
AAPL   122.80 (+1.50%)
MSFT   233.03 (+1.76%)
FB   262.09 (+2.91%)
GOOGL   2,026.49 (+0.52%)
AMZN   3,071.54 (+0.47%)
TSLA   672.48 (-1.43%)
NVDA   545.85 (+2.55%)
BABA   239.76 (-0.17%)
CGC   32.42 (-2.38%)
GE   12.63 (-1.02%)
MU   91.20 (+3.50%)
NIO   46.10 (-1.52%)
AMD   84.02 (+1.94%)
T   28.00 (-2.20%)
F   11.72 (-0.34%)
ACB   10.65 (-1.57%)
DIS   189.03 (-1.02%)
BA   211.68 (-2.20%)
NFLX   540.54 (-1.13%)
BAC   34.94 (-2.76%)
S&P 500   3,831.70 (+0.06%)
DOW   31,063.14 (-1.08%)
QQQ   314.93 (+0.67%)
AAPL   122.80 (+1.50%)
MSFT   233.03 (+1.76%)
FB   262.09 (+2.91%)
GOOGL   2,026.49 (+0.52%)
AMZN   3,071.54 (+0.47%)
TSLA   672.48 (-1.43%)
NVDA   545.85 (+2.55%)
BABA   239.76 (-0.17%)
CGC   32.42 (-2.38%)
GE   12.63 (-1.02%)
MU   91.20 (+3.50%)
NIO   46.10 (-1.52%)
AMD   84.02 (+1.94%)
T   28.00 (-2.20%)
F   11.72 (-0.34%)
ACB   10.65 (-1.57%)
DIS   189.03 (-1.02%)
BA   211.68 (-2.20%)
NFLX   540.54 (-1.13%)
BAC   34.94 (-2.76%)
S&P 500   3,831.70 (+0.06%)
DOW   31,063.14 (-1.08%)
QQQ   314.93 (+0.67%)
AAPL   122.80 (+1.50%)
MSFT   233.03 (+1.76%)
FB   262.09 (+2.91%)
GOOGL   2,026.49 (+0.52%)
AMZN   3,071.54 (+0.47%)
TSLA   672.48 (-1.43%)
NVDA   545.85 (+2.55%)
BABA   239.76 (-0.17%)
CGC   32.42 (-2.38%)
GE   12.63 (-1.02%)
MU   91.20 (+3.50%)
NIO   46.10 (-1.52%)
AMD   84.02 (+1.94%)
T   28.00 (-2.20%)
F   11.72 (-0.34%)
ACB   10.65 (-1.57%)
DIS   189.03 (-1.02%)
BA   211.68 (-2.20%)
NFLX   540.54 (-1.13%)
BAC   34.94 (-2.76%)
Log in
NYSE:BDX

Becton, Dickinson and Stock Forecast, Price & News

$241.99
-5.16 (-2.09 %)
(As of 02/26/2021 02:19 PM ET)
Add
Compare
Today's Range
$241.88
Now: $241.99
$246.53
50-Day Range
$246.02
MA: $256.66
$263.30
52-Week Range
$197.75
Now: $241.99
$284.97
Volume17,436 shs
Average Volume1.39 million shs
Market Capitalization$70.31 billion
P/E Ratio88.64
Dividend Yield1.35%
Beta0.79
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Becton, Dickinson and logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07588710
Phone201-847-6800
Employees72,000
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.12 billion
Cash Flow$16.33 per share
Book Value$81.98 per share

Profitability

Net Income$874 million

Miscellaneous

Market Cap$70.31 billion
Next Earnings Date5/6/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

2.36 out of 5 stars

Medical Sector

17th out of 1,956 stocks

Surgical & Medical Instruments Industry

2nd out of 165 stocks

Analyst Opinion: 3.3Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
$241.99
-5.16 (-2.09 %)
(As of 02/26/2021 02:19 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BDX News and Ratings via Email

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Becton, Dickinson and (NYSE:BDX) Frequently Asked Questions

Is Becton, Dickinson and a buy right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Becton, Dickinson and in the last twelve months. There are currently 6 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Becton, Dickinson and stock.
View analyst ratings for Becton, Dickinson and
or view top-rated stocks.

What stocks does MarketBeat like better than Becton, Dickinson and?

Wall Street analysts have given Becton, Dickinson and a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Becton, Dickinson and wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Becton, Dickinson and's next earnings date?

Becton, Dickinson and is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Becton, Dickinson and
.

How were Becton, Dickinson and's earnings last quarter?

Becton, Dickinson and Company (NYSE:BDX) issued its earnings results on Wednesday, February, 3rd. The medical instruments supplier reported $4.55 earnings per share for the quarter, beating the consensus estimate of $3.14 by $1.41. The medical instruments supplier had revenue of $5.32 billion for the quarter, compared to analyst estimates of $4.87 billion. Becton, Dickinson and had a trailing twelve-month return on equity of 13.30% and a net margin of 5.11%. The business's quarterly revenue was up 25.8% compared to the same quarter last year. During the same period in the previous year, the business posted $2.65 earnings per share.
View Becton, Dickinson and's earnings history
.

How has Becton, Dickinson and's stock price been impacted by Coronavirus?

Becton, Dickinson and's stock was trading at $231.91 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BDX stock has increased by 5.3% and is now trading at $244.29.
View which stocks have been most impacted by COVID-19
.

How often does Becton, Dickinson and pay dividends? What is the dividend yield for Becton, Dickinson and?

Becton, Dickinson and declared a quarterly dividend on Monday, January 25th. Investors of record on Wednesday, March 10th will be given a dividend of $0.83 per share on Wednesday, March 31st. This represents a $3.32 annualized dividend and a yield of 1.36%. The ex-dividend date of this dividend is Tuesday, March 9th.
View Becton, Dickinson and's dividend history
.

Is Becton, Dickinson and a good dividend stock?

Becton, Dickinson and pays an annual dividend of $3.32 per share and currently has a dividend yield of 1.35%. Becton, Dickinson and has been increasing its dividend for 50 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Becton, Dickinson and is 32.55%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Becton, Dickinson and will have a dividend payout ratio of 24.79% next year. This indicates that Becton, Dickinson and will be able to sustain or increase its dividend.
View Becton, Dickinson and's dividend history.

What guidance has Becton, Dickinson and issued on next quarter's earnings?

Becton, Dickinson and updated its FY21 earnings guidance on Thursday, February, 4th. The company provided EPS guidance of $12.75-12.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.68. The company issued revenue guidance of +12-14% (implying $19.17-19.51 billion), compared to the consensus revenue estimate of $19.33 billion.

What price target have analysts set for BDX?

13 Wall Street analysts have issued 12 month target prices for Becton, Dickinson and's stock. Their forecasts range from $265.00 to $300.00. On average, they expect Becton, Dickinson and's stock price to reach $281.55 in the next year. This suggests a possible upside of 15.3% from the stock's current price.
View analysts' price targets for Becton, Dickinson and
or view top-rated stocks among Wall Street analysts.

Who are Becton, Dickinson and's key executives?

Becton, Dickinson and's management team includes the following people:
  • Mr. Vincent A. Forlenza, Exec. Chairman (Age 68, Pay $2.51M)
  • Mr. Thomas E. Polen Jr., Pres, CEO & Director (Age 48, Pay $2.11M)
  • Mr. Christopher R. Reidy, Exec. VP, CFO & Chief Admin. Officer (Age 64, Pay $1.4M)
  • Mr. Samrat S. Khichi, Exec. VP of Regulatory & Gov. Affairs and Gen. Counsel (Age 54, Pay $2.19M)
  • Mr. Alberto Mas, Exec. VP & Pres of the Medical Segment (Age 60, Pay $1.15M)
  • Mr. Thomas J. Spoerel, VP, Controller & Chief Accounting Officer (Age 43)
  • Dr. John A. DeFord, Exec. VP of R&D and CTO (Age 59)
  • Jerry Flasz, Exec. VP of Global Services & Chief Information Officer
  • Ms. Monique N. Dolecki, Sr. VP of Investor Relations
  • Michelle Quinn, Sr. VP and Chief Ethics & Compliance Officer

What is Tom Polen's approval rating as Becton, Dickinson and's CEO?

136 employees have rated Becton, Dickinson and CEO Tom Polen on Glassdoor.com. Tom Polen has an approval rating of 91% among Becton, Dickinson and's employees. This puts Tom Polen in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Becton, Dickinson and's key competitors?

What other stocks do shareholders of Becton, Dickinson and own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Becton, Dickinson and investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), AT&T (T), NVIDIA (NVDA), The Walt Disney (DIS), Abbott Laboratories (ABT), Intel (INTC), Verizon Communications (VZ), Cisco Systems (CSCO) and CVS Health (CVS).

What is Becton, Dickinson and's stock symbol?

Becton, Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

Who are Becton, Dickinson and's major shareholders?

Becton, Dickinson and's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.64%), Price T Rowe Associates Inc. MD (4.01%), Morgan Stanley (2.70%), FMR LLC (1.67%), Fundsmith LLP (1.50%) and Fiera Capital Corp (1.36%). Company insiders that own Becton, Dickinson and stock include Alexandre Conroy, Betty D Larson, Catherine M Burzik, Charles R Bodner, Claire Fraser, James C Lim, Patrick Kaltenbach, Ribo Alberto Mas, Roland Goette, Samrat S Khichi, Simon D Campion, Thomas J Spoerel and Vincent A Forlenza.
View institutional ownership trends for Becton, Dickinson and
.

Which major investors are selling Becton, Dickinson and stock?

BDX stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, FMR LLC, Barclays PLC, Public Employees Retirement Association of Colorado, JPMorgan Chase & Co., Bank of New York Mellon Corp, The Manufacturers Life Insurance Company , and Alta Capital Management LLC. Company insiders that have sold Becton, Dickinson and company stock in the last year include Patrick Kaltenbach, and Roland Goette.
View insider buying and selling activity for Becton, Dickinson and
or view top insider-selling stocks.

Which major investors are buying Becton, Dickinson and stock?

BDX stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., California Public Employees Retirement System, Flossbach Von Storch AG, Lazard Freres Gestion S.A.S., Viking Global Investors LP, Morgan Stanley, Healthcare of Ontario Pension Plan Trust Fund, and Value Partners Investments Inc..
View insider buying and selling activity for Becton, Dickinson and
or or view top insider-buying stocks.

How do I buy shares of Becton, Dickinson and?

Shares of BDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Becton, Dickinson and's stock price today?

One share of BDX stock can currently be purchased for approximately $244.29.

How much money does Becton, Dickinson and make?

Becton, Dickinson and has a market capitalization of $70.98 billion and generates $17.12 billion in revenue each year. The medical instruments supplier earns $874 million in net income (profit) each year or $10.20 on an earnings per share basis.

How many employees does Becton, Dickinson and have?

Becton, Dickinson and employs 72,000 workers across the globe.

What is Becton, Dickinson and's official website?

The official website for Becton, Dickinson and is www.bd.com.

Where are Becton, Dickinson and's headquarters?

Becton, Dickinson and is headquartered at 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417.

How can I contact Becton, Dickinson and?

Becton, Dickinson and's mailing address is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. The medical instruments supplier can be reached via phone at 201-847-6800.


This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.